Abstract
Human liver slices, human liver microsomes, and rat liver microsomes were used to investigate the metabolism of3H-taxol. The effects of drugs frequently coadministered with taxol and the effects of several cytochrome P450 system probes were studied. In all, 16 compounds were screened. After incubation with liver slices or with microsomal protein,3H-taxol was converted into several radioactive species resolved by HPLC. There were qualitative and quantitative species differences in the metabolism of taxol. The pattern of metabolism was similar for both human-derived preparations, with 6α-hydroxytaxol being the major metabolite peak. In drug interaction studies performed with human liver microsomes, cimetidine 80 μM, and diphenhydramine 200 μM, had little or no effect on 6α-hydroxytaxol formation. Quinidine, ketoconazole, dexamethasone and Cremophor EL inhibited 6α-hydroxytaxol formation with IC50 values of 36 μM, 37 μM, 16 μM and 1 μl/ml, respectively, but these concentrations exceed the usual clinical range. Cremophor EL also inhibited microsomal metabolism of taxol, but at 2 μl/ml it had little or no effect on 6α-hydroxytaxol production by human liver slices. These results suggest that: (1) taxol is metabolized by the cytochrome P450 system; (2) taxol metabolism is different in humans than in rats; (3) taxol metabolism in humans is unlikely to be altered by cimetidine, dexamethasone, or diphenhydramine, drugs regularly coadministered with taxol; (4) taxol metabolism can be indirectly affected by Cremophor EL, the formulation vehicle; (5) taxol metabolism may be altered by concentrations of ketoconazole achievable in humans only at very high doses; and (6) taxol metabolism and drug interaction studies of clinical relevance can be performed in vitro with human liver microsomes and human liver slices, but not with rat liver preparations.
Similar content being viewed by others
References
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248
Brown T, Havlin K, Weiss G, Cagnola J, Koeller J, Kuhn J, Rizzo J, Craig J, Phillips J, Von Hoff D (1991) A phase I trial of taxol given by a 6-hour intravenous infusion. J Clin Oncol 9: 1261
Carruthers SG, Shoeman DW, Hignite CE, Azarnoff DL (1978) Correlation between plasma diphenhydramine level and sedative and antihistamine effects. Clin Pharmacol Ther 23:375
Cragg GM, Snader KM (1991) Taxol: the supply issue. Cancer Cells 3:233
Cresteil T, Monsarrat B, Alvinerie P, Tréluyer JM, Vieira I, Wright M (1994) Taxol metabolism by human liver microsomes: identification of cytochrome P450 isozymes involved in its biotransformation. Cancer Res 54:386
Daneshmend TK, Warnock DW (1988) Clinical pharmacokinetics of ketoconazole. Clin Pharmacokinet 14:13
Douglas WW (1985) Histamine and 5-hydroxytryptamine (serotonin) and their antagonists. In: Gilman AG, Goodman LS, Rall TW, Murad F (eds) The Pharmacological basis of therapeutics, 7th edn, Macmillan, New York, p 605
Einzig AI, Hochster H, Wiernik PH, Trump DL, Dutcher JP, Garowski E, Sasloff J, Smith TJ (1991) A phase II study of taxol in patients with malignant melanoma. Invest New Drugs 9:59
First MR, Schroeder TJ, Weiskittel P, Myre SA, Alexander JW, Pesce AJ (1989) Concomitant administration of cyclosporin and ketoconazole in renal transplant recipients. Lancet 2:1198
Follath F, Ganzinger U, Schuetz E (1983) Reliability of antiarrhythmic drug plasma concentration monitoring. Clin Pharmacokinet 8:63
Guengerich FP, Muller-Enoch D, Blair IA (1986) Oxidation of quinidine by human liver cytochrome P-450. Mol Pharmacol 30:287
Harris JW, Katki A, Anderson LW, Chmurny GN, Paukstelis JV, Collins JM (1994) Isolation, structural determination, and biological activity of 6α-hydroxytaxol, the principal human metabolite of taxol. J Med Chem 37:706
Holmes FA, Walters RS, Theriault RL, Forman AD, Newton LK, Raber MN, Buzdar AU, Frye DK, Hortobagyi GN (1991) Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer. J Natl Cancer Inst 83:1797
Holton RA, Somoza C, Kim HB, Liang F, Biediger RJ, Boatman PD, Shindo M, Smith CC, Kim SC, Nadizadeh H, Suzuki Y, Tao CL, Vu P, Tang SH, Zhang PS, Murthi KK, Gentile LN, Liu JH (1994) First total synthesis of taxol. 1. Functionalization of the B ring. J Am Chem Soc 116:1597
Holton RA, Kim HB, Somoza C, Liang F, Biediger RJ, Boatman PD, Shindo M, Smith CC, Kim SC, Nadizadeh H, Suzuki Y, Tao CL, Vu P, Tang SH, Zhang PS, Murthi KK, Gentile LN, Liu JH (1994) First total synthesis of taxol. 2. Completion of the C and D rings. J Am Chem Soc 116:1599
Klecker RW, Jamis-Dow CA, Egorin MJ, Erkmen K, Parker RJ, Stevens R, Collins JM (1994) Effect of cimetidine, probenecid and ketoconazole on the distribution, biliary secretion and metabolism of3H-taxol in the sprague-dawley rat. Drug Metab Dispos 22:254
Knodell RG, Browne DG, Gwozdz GP, Brian WR, Guengerich FP (1991) Differential inhibition of individual human liver cytochromes P-450 by cimetidine. Gastroenterology 101:1680
Kumar GN, Oatis JEJ, Thornburg KR, Heldich FJ, Hazard ESI, Walle T (1994) 6α-Hydroxytaxol: isolation and identification of the major metabolite of taxol in human liver microsomes. Drug Metab Dispos 22:177
Maurice M, Pichard L, Daujat M, Fabre I, Joyeux H, Domergue J, Maurel P (1992) Effects of imidazole derivatives on cytochromes P450 from human hepatocytes in primary culture. FASEB J 6:752
McGuire WP, Rowinsky EK, Rosenshein NB, Grumbine FC, Ettinger DS, Armstrong DK, Donehower RC (1989) Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms. Ann Intern Med 111:273
Monsarrat B, Mariel E, Cros S, Garès M, Guénard D, Guéritte-Voegelein F, Wright M (1990) Taxol metabolism. Isolation and identification of three major metabolites of taxol in rat bile. Drug Metab Dispos 18:895
Monsarrat B, Alvinerie P, Wright M, Dubois J, Guéritte-Voegelein F, Guénard D, Donehower RC, Rowinsky EK (1993) Hepatic metabolism and biliary excretion of taxol in rats and humans. J Natl Cancer Inst Monogr 15:39
Nicolaou KC, Yang Z, Liu JJ, Ueno H, Nantermet PG, Guy RK, Claiborne CF, Renaud J, Couladouros EA, Paulvannan K, Sorensen EJ (1994) Total synthesis of taxol. Nature 367:630
Peereboom DM, Donehower RC, Eisenhauer EA, McGuire WP, Onetto N, Hubbard JL, Piccart M, Gianni L, Rowinsky EK (1993) Successful re-treatment with taxol after major hypersensitivity reactions. J Clin Oncol 11:885
Pichard L, Fabre I, Daujat M, Domergue J, Joyeux H, Maurel P (1992) Effect of corticosteroids on the expression of cytochromes P450 and on cyclosporin A oxidase activity in primary cultures of human hepatocytes. Mol Pharmacol 41:1047
Reed E, Sarosy G, Jamis-Dow CA, Klecker R, Kohn E, Link C, Christian M, Davis P, Collins J (1993) Cimetidine does not influence taxol steady-state plasma levels. Proc Am Assoc Cancer Res 34:395
Wani MC, Taylor HL, Wall ME, Coggon P, McPhail AT (1971) Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J Am Chem Soc 93:2325
Webster L, Linsenmeyer M, Millward M, Morton C, Bishop J, Woodcock D (1993) Measurement of Cremophor EL following taxol: plasma levels sufficient to reverse drug exclusion mediated by the multidrug-resistant phenotype. J Natl Cancer Inst 85: 1685
Weiss RB, Donehower RC, Wiernik PH, Ohnuma T, Gralla RJ, Trump DL, Baker J Jr, Van Echo DA, Von Hoff DD, Leyland-Jones B (1990) Hypersensitivity reactions from taxol. J Clin Oncol 8:1263
Wilson WH, Berg SL, Bryant G, Wittes RE, Bates S, Fojo A, Steinberg SM, Goldspiel BR, Herdt J, O'Shavghnessy J, Balis FM, Chabner BA (1994) Paclitaxel in doxorubicin-refractory or mitoxantrone-refractory breast cancer: a phase I/II trial of 96-hour infusion. J Clin Oncol 12:1621
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jamis-Dow, C.A., Klecker, R.W., Katki, A.G. et al. Metabolism of taxol by human and rat liver in vitro: A screen for drug interactions and interspecies differences. Cancer Chemother. Pharmacol. 36, 107–114 (1995). https://doi.org/10.1007/BF00689193
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00689193